von Tobias Borgers | Nov 15, 2023 | Fachzeitschriften
Im kommenden Frühjahr soll sie betriebsbereit sein: Die lernende Fabrik Solida 1 (SOL-1) in Leverkusen wird eine der modernsten Produktionsanlagen für Arzneimittel weltweit. Sie ist Teil eines milliardenschweren Investitionsprogramms, mit dem die Bayer AG das...
von Tobias Borgers | Nov 8, 2023 | IMA
On July 18th 2023, IMA completed the closing for the purchase of 70% of Mespic S.r.l., a company based in Faenza (Ravenna), and 100% of its Illinois-based subsidiary Mespic North America Corporation, from its sole shareholder Holding FGLG S.r.l.. Mespic, founded in...
von Tobias Borgers | Nov 8, 2023 | Markt
Laks Pernenkil, principal and practice leader, US Life Sciences Product & Supply Operations, Deloitte, discusses the impact that digitalization is having on data generation and data integrity in bio/pharma manufacturing.A discussion with Laks Pernenkil, principal...
von Tobias Borgers | Nov 8, 2023 | Markt
Vedanta Biosciences, a clinical-stage company, has raised $106.5million to support its lead candidate VE303 that aims to stop recurrent Clostridioides difficile infection (CDI). The company has also announced a phase 2 study of VE202 for ulcerative colitis. It says...
von Tobias Borgers | Okt 25, 2023 | Markt
An influential North America Contract Manufacturing Market report is useful to get answers for several questions that include but are not limited to; who will buy your product? Who are your ideal customer personas? How often will they buy? What do they need?...
